ENOSIS MASTICHOPARAGOGON CHIOU - Greece 

Ranking results:

Past rankings:

2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 4.302.000 459.000 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
BIOTECH VANA SL1
CONSIGLIO NAZIONALE DELLE RICERCHE1
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA1
GALENN1
HAROKOPIO UNIVERSITY1
IASIS PHARMACEUTICALS HELLAS BIOMICHANIA KAI EMPORIA FARMAKEYTIKON CHIMIKON KAI KALLYNTIKON PROIONTON ABEE1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTE OF ORGANIC CHEMISTRY WITH CENTRE OF PHYTOCHEMISTRY BULGARIAN ACADEMY OF SCIENCES1
MARASCIO FERNANDO1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
PERSPECTUM DIAGNOSTICS1
PHYCOSOURCE SARL1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
RANDOX LABORATORIES1
SANOFIS AVENTIS DEUTSCHLAND1
UNIVERSITE PARIS DESCARTES1
UNIVERZITET U ISTOCNOM SARAJEVU1
UNIVERZITET U NOVOM SADU MEDICINSKI FAKULTET1
VENUSROUZES LABSOLUTIONS1
VIVACELL BIOTECHNOLOGY1

Constancy:

Total number of partners: 20
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 20
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2016-03-01Exploitation of aromatic plants’ by-products for the development of novel cosmeceuticals and food supplements. EXANDASparticipant2.178.0009
2016-03-01Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH). MAST4HEALTHparticipant2.124.00013